Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.30 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12880239 | 0.89 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL9420277 | 0.87 | ALDH1A1 (0.37) | ALDH1A1PTGS2 | |
| SCHEMBL62389 | 0.87 | — | — | |
| SCHEMBL10911878 | 0.87 | — | — | |
| SCHEMBL15668736 | 0.85 | — | — | |
| SCHEMBL11580369 | 0.85 | — | — | |
| Nitric Acid SCHEMBL15562819 | 0.84 | CA5A (0.35) | ALDH1A1CA5ACA5B | |
| Nitric Acid SCHEMBL44182 | 0.84 | CA5A (0.35) | ALDH1A1CA5ACA5B | |
| SCHEMBL7919622 | 0.84 | THRB (0.39) | ALDH1A1 | |
| Nitric Acid SCHEMBL7262025 | 0.84 | CA5A (0.35) | ALDH1A1CA5ACA5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117650279-A | Nonaqueous electrolyte and lithium metal battery | 蜂巢能源科技股份有限公司 | 2024-03-05 | — | — | CN | claimed |
| CN-114585356-A | Methods of preventing or treating diseases associated with VEGFR and/or VEGF inhibition | 上海岸阔医药科技有限公司 | 2022-06-03 | — | — | CN | claimed |
| WO-2021073535-A1 | METHOD FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH ADMINISTRATION OF VEGFR AND/OR VEGF INHIBITOR | 上海岸阔医药科技有限公司 | 2021-04-22 | — | — | WO | claimed |
| US-10562873-B1 | Methods of producing glycidyl nitrate | Northrop Grumman Innovation Systems, Inc. (US) | 2020-02-18 | — | — | US | claimed |
| US-6870061-B2 | Continuous process and system for production of glycidyl nitrate from glycerin, nitric acid and caustic and conversion of glycidyl nitrate to poly(glycidyl nitrate) | ALLIANT TECHSYSTEMS INC. (US) | 2005-03-22 | — | — | US | claimed |
| US-20040138481-A1 | Continuous process and system for production of glycidyl nitrate from glycerin, nitric acid and caustic and conversion of glycidyl nitrate to poly(glycidyl nitrate) | NORTHROP GRUMMAN SYSTEMS CORPORATION | 2004-07-15 | — | — | US | claimed |
| WO-2001002336-A1 | PROCESS FOR THE PRODUCTION OF GLYCEROL DINITRATES | QINETIQ LIMITED (GB) | 2001-01-11 | — | — | WO | claimed |
| US-20250270178-A1 | METHODS OF PRODUCING A NITRATE ESTER | NORTHROP GRUMMAN SYSTEMS CORPORATION | 2025-08-28 | — | — | US | disclosed |
| US-20240415795-A1 | TOPICAL FORMULATIONS OF NITROGLYCERIN | PERMEATUS, INC. | 2024-12-19 | — | — | US | disclosed |
| US-12070440-B2 | Topical formulations of nitroglycerin | PERMEATUS, INC. (US) | 2024-08-27 | — | — | US | disclosed |
| CN-117650279-A | Nonaqueous electrolyte and lithium metal battery | 蜂巢能源科技股份有限公司 | 2024-03-05 | — | — | CN | disclosed |
| WO-2024006305-A1 | TOPICAL FORMULATIONS OF NITROGLYCERIN | PERMEATUS, INC. (US) | 2024-01-04 | — | — | WO | disclosed |
| US-20230414551-A1 | TOPICAL FORMULATIONS OF NITROGLYCERIN | PERMEATUS, INC. | 2023-12-28 | — | — | US | disclosed |
| US-6245576-B1 | ANALYZING SAMPLES FOR ENERGETIC MATERIALS; BY HEATING SAMPLES IN CHAMBER UNDER PRESSURE AND DETECTING CHEMILUMINESCENT EMISSION | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITTANIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND OF DEFENCE EVALUATION RESEARCH AGENCY (GB) | 2001-06-12 | — | — | US | disclosed |
| WO-2001029111-A1 | POLYMERIZATION OF POLY(GLYCIDYL NITRATE) FROM HIGH PURITY GLYCIDYL NITRATE SYNTHESIZED FROM GLYCEROL | ALLIANT TECHSYSTEMS INC. (US) | 2001-04-26 | — | — | WO | disclosed |
| US-6180664-B1 | CARDIOVASCUALR DISORDERS; IMPOTENCY | ISIS PHARMA GMBH (DE) | 2001-01-30 | — | — | US | disclosed |
| WO-2001002336-A1 | PROCESS FOR THE PRODUCTION OF GLYCEROL DINITRATES | QINETIQ LIMITED (GB) | 2001-01-11 | — | — | WO | disclosed |
| EP-0904531-A1 | METHOD OF EXPLOSIVES DETECTION | THE SECRETARY OF STATE FOR DEFENCE (GB) | 1999-03-31 | — | — | EP | disclosed |
| WO-1997047958-A1 | METHOD OF EXPLOSIVES DETECTION | THE SECRETARY OF STATE FOR DEFENCE (GB) | 1997-12-18 | — | — | WO | disclosed |
| US-5625083-A | VASODILATORS, ANTIHYPERTENSIVE AGENTS, BRONCHODILATORS | MANEVICH, YEFIM | 1997-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10562873-B1 | Methods of producing glycidyl nitrate | GMPS, GK, GAPDH | ALDH1A1 968/4885PTGS2 33/4885CA5A 829/4885 |
| US-20250270178-A1 | METHODS OF PRODUCING A NITRATE ESTER | NOS2, NOS3, NOS1 | ALDH1A1 389/4885PTGS2 359/4885CA5A 616/4885 |
| US-20040138481-A1 | Continuous process and system for production of glycidyl nitrate from glycerin, nitric acid and caustic and conversion of glycidyl nitrate to poly(glycidyl nitrate) | GMNN, GLMN, GMPS | ALDH1A1 1887/4885PTGS2 43/4885CA5A 541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.